Therapentin-90
Product Images NDC 68405-068

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Therapentin-90 (NDC 68405-068). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physician Therapeutics Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adjunctive Therapy Studies (Adjunctivetherapystudies)

Adjunctive Therapy Studies (Adjunctivetherapystudies)
A scatter plot showing percentage difference on the vertical axis and daily dose in milligrams on the horizontal axis. It features data points from three studies labeled 'a', 'b', and 'c' with varying doses at 600, 900, 1200, and 1800 mg, showing how the percentage difference changes with dosage in each study.*
FDA Label Image

Gabapentin (Gabapentin)

Gabapentin (Gabapentin)
Label for Gabapentin 300mg capsule, manufactured by Camber PHM, with a quantity of 60 capsules. The label includes the lot number GBC323QE, expiration date 03/13, and compares to Neurontin with NDC 31722-0222-05. It also contains dosage instructions advising to follow doctor's directions and a caution about federal law and storage temperature.*
FDA Label Image

Proportion Of Responders (Proportionofresponders)

Proportion Of Responders (Proportionofresponders)
A bar graph showing the percentage of responders at endpoint across two studies. Study 1 compares PBO and GBP 3600 with percentages 12% and 29%, respectively. Study 2 compares PBO, GBP 1800, and GBP 2400 with percentages 14%, 32%, and 34%, respectively. Statistical significance is indicated with markers for p < 0.01 and p < 0.001.*
FDA Label Image

Strformulagabapentin (Strformulagabapentin)

Strformulagabapentin (Strformulagabapentin)
Chemical structure of the active ingredient in Therapentin-90 from Physician Therapeutics LLC, showing a cyclohexane ring with side chains including an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*
FDA Label Image

Theramine 90 (Theramine90)

Theramine 90 (Theramine90)
The image shows directions for use, ingredient information, and warnings for Therapentin-90, a medical food by Physician Therapeutics LLC. It instructs adult use under medical supervision, specifies storage conditions, and warns to keep out of children's reach. Ingredients include a proprietary amino acid blend, Griffonia seed extract, whey protein hydrolysate, and other components. The product contains 90 capsules.*
FDA Label Image

Therapentin 90 (Therapentin90)

Therapentin 90 (Therapentin90)
The image shows the label for Therapentin-90 by Physician Therapeutics LLC with NDC 68405-068. It features the product name prominently along with the Physician Therapeutics logo. The label indicates it contains Theramine 90 capsules and Gabapentin 300 mg, 60 capsules in a co-pack. It also states "Rx Only" and notes no refills without physician authorization.*
FDA Label Image

Weekly Mean Pain Scores 1 (Weeklymeanpainscores1)

Weekly Mean Pain Scores 1 (Weeklymeanpainscores1)
A line graph showing mean pain scores over eight weeks comparing placebo and Gabapentin at 3600 mg/day. The graph distinguishes between a 4-week dose titration period and a 4-week fixed dose period. Gabapentin shows a significant decrease in mean pain score over time compared to placebo, with p-values less than 0.01 indicated.*
FDA Label Image

Weekly Mean Pain Scores 2 (Weeklymeanpainscores2)

Weekly Mean Pain Scores 2 (Weeklymeanpainscores2)
A line graph depicting mean pain scores over 8 weeks comparing placebo and Gabapentin at 3600 mg/day. The x-axis represents weeks, and the y-axis shows mean pain scores from 0 to 10. The graph includes a 4-week dose titration period and a 4-week fixed dose period, with Gabapentin showing a significant reduction in pain scores compared to placebo throughout the study period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.